The aim of this document is to support Clostridium difficile infection (CDI) surveillance in Europe with appropriate microbiological standardised procedures, and can be used by microbiologists, infectious diseases specialists and infection prevention control specialists.
This ECDC study protocol describes the technical requirements for implementing future EU-level genomic-based surveillance of carbapenem-resistant and/or colistin-resistant Enterobacteriaceae.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 8-14 July 2018 and includes updates on carbapenemase-producing (OXA-48) Klebsiella pneumoniae, dengue, Ebola virus disease, poliomyelitis, MERS-CoV, mass gathering monitoring (FIFA Men's Football World Cup), measles, poliovirus type 2, rubella, Vibrio growth in the Baltic Sea, and West Nile virus.
This rapid risk assessment evaluates the risk of transmission and further spread of OXA-48-producing Klebsiella pneumonia e ST392 from travellers having sought medical care in Gran Canaria to healthcare facilities in their country of origin in the EU/EEA.
This risk assessment will discuss CAZ-AVI resistance in brief, review the recent literature reporting resistance of CRE to CAZ-AVI, and assess the risk for the EU/EEA countries.